KORU Medical Systems Inc. (KRMD)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally.
It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing.
The company also provides education and training materials to clinicians, patients, and patient advocates.
It sells its products through direct sales and medical device distributors, as well as online.
KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Country | United States |
IPO Date | Apr 5, 1994 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 82 |
CEO | Linda M. Tharby |
Contact Details
Address: 24 Carpenter Road Chester, New York United States | |
Website | https://www.korumedical.com |
Stock Details
Ticker Symbol | KRMD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000704440 |
CUSIP Number | 759910102 |
ISIN Number | US7599101026 |
Employer ID | 13-3044880 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Linda M. Tharby | President, Chief Executive Officer & Director |
Christopher Pazdan | Chief Operating Officer |
Thomas Adams | Chief Financial Officer, Secretary & Treasurer |
Kenneth Miller | Chief Commercial Officer |
Rob Cannon | Vice President of Sales |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 21, 2025 | SCHEDULE 13D/A | [Amend] Filing |
Jan 21, 2025 | 4 | Filing |
Jan 13, 2025 | 8-K | Current Report |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4 | Filing |
Jan 03, 2025 | 4/A | [Amend] Filing |